Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1988 1
1989 1
1993 1
1994 2
1995 1
1996 2
1998 3
2000 1
2001 1
2004 1
2014 1
2016 1
2017 2
2018 1
2019 1
2020 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

20 results

Results by year

Filters applied: . Clear all
Page 1
Dose-response relationship of a new Timothy grass pollen allergoid in comparison with a 6-grass pollen allergoid.
Pfaar O, Hohlfeld JM, Al-Kadah B, Hauswald B, Homey B, Hunzelmann N, Schliemann S, Velling P, Worm M, Klimek L. Pfaar O, et al. Clin Exp Allergy. 2017 Nov;47(11):1445-1455. doi: 10.1111/cea.12977. Epub 2017 Oct 16. Clin Exp Allergy. 2017. PMID: 28696503 Clinical Trial.
Based on the extensive cross-reactivity among Pooideae species, it has been suggested that grass pollen extracts could be prepared from a single species, rather than from a multiple species mixture. OBJECTIVE: To find the optimal dose of a Phleum pratense (P. pratense) all …
Based on the extensive cross-reactivity among Pooideae species, it has been suggested that grass pollen extracts could be prepared from a si …
How to recognise and deal with dubious virus sequences?
Zell R, Gorbalenya AE, Knowles NJ, Simmonds P, Skern T. Zell R, et al. Infect Genet Evol. 2020 Jul;81:104242. doi: 10.1016/j.meegid.2020.104242. Epub 2020 Feb 13. Infect Genet Evol. 2020. PMID: 32061897 No abstract available.
Kiwi allergens and their cross-reactivity with birch, rye, timothy, and mugwort pollen.
Rudeschko O, Fahlbusch B, Steurich F, Schlenvoigt G, Jäger L. Rudeschko O, et al. J Investig Allergol Clin Immunol. 1998 Mar-Apr;8(2):78-84. J Investig Allergol Clin Immunol. 1998. PMID: 9615299
In order to study kiwi allergens and examine their cross-reactivity to birch, rye, timothy, and mugwort pollen, immunoblot and enzyme immunoassay (EIA) inhibition tests were performed with self-prepared kiwi extract. ...Immunoblot results revealed a broad spectrum of IgE s …
In order to study kiwi allergens and examine their cross-reactivity to birch, rye, timothy, and mugwort pollen, immunoblot and enzyme …
Soil microarthropods alter the outcome of plant-soil feedback experiments.
Kuťáková E, Cesarz S, Münzbergová Z, Eisenhauer N. Kuťáková E, et al. Sci Rep. 2018 Aug 9;8(1):11898. doi: 10.1038/s41598-018-30340-w. Sci Rep. 2018. PMID: 30093622 Free PMC article.
We performed a PSF experiment in microcosms with two plant species, Phleum pratense and Poa pratensis. We added a model microarthropod community consisting of three fungivorous springtail species (Proisotoma minuta, Folsomia candida, and Sinella curviseta) and a predatory …
We performed a PSF experiment in microcosms with two plant species, Phleum pratense and Poa pratensis. We added a model microarthropo …
Group 5 allergens of timothy grass (Phl p 5) bear cross-reacting T cell epitopes with group 1 allergens of rye grass (Lol p 1).
Müller WD, Karamfilov T, Bufe A, Fahlbush B, Wolf I, Jäger L. Müller WD, et al. Int Arch Allergy Immunol. 1996 Apr;109(4):352-5. doi: 10.1159/000237262. Int Arch Allergy Immunol. 1996. PMID: 8634519
Selected human T cell clones reactive with group 5 allergens of timothy grass (Phl p 5) were cross-stimulated in specific proliferation assays with group 1 allergens of rye grass (Lol p 1). ...
Selected human T cell clones reactive with group 5 allergens of timothy grass (Phl p 5) were cross-stimulated in specific proliferati …
NMR-based metabolomics and bioassays to study phytotoxic extracts and putative phytotoxins from Mediterranean plant species.
Scognamiglio M, Graziani V, Tsafantakis N, Esposito A, Fiorentino A, D'Abrosca B. Scognamiglio M, et al. Phytochem Anal. 2019 Sep;30(5):512-523. doi: 10.1002/pca.2842. Epub 2019 Jun 20. Phytochem Anal. 2019. PMID: 31222865
METHODS: Plant extracts derived from five Mediterranean donor species (Pistacia lentiscus, Bellis sylvestris, Phleum subulatum, Petrohrhagia saxifraga and Melilotus neapolitana) were used to treat the hydroponic cultures of three receiving plants (Triticum durum, Triticum …
METHODS: Plant extracts derived from five Mediterranean donor species (Pistacia lentiscus, Bellis sylvestris, Phleum subulatum, Petro …
A two-site monoclonal antibody ELISA for the quantification of group V allergens in grass extracts.
Fahlbusch B, Schlenvoigt G, Müller WD, Weber B, Jäger L. Fahlbusch B, et al. Clin Exp Allergy. 1994 Aug;24(8):752-7. doi: 10.1111/j.1365-2222.1994.tb00986.x. Clin Exp Allergy. 1994. PMID: 7982125
The group V content ranged between 73 and 673 micrograms/ml in the extracts. The International Standard of Phleum pratense (IS 82/520) contains 400 micrograms/ml Phl p V. A good correlation was observed between the group V content and RAST inhibition, with the exception of …
The group V content ranged between 73 and 673 micrograms/ml in the extracts. The International Standard of Phleum pratense (IS 82/520 …
Reduced CD62L Expression on T Cells and Increased Soluble CD62L Levels Predict Molecular Response to Tyrosine Kinase Inhibitor Therapy in Early Chronic-Phase Chronic Myelogenous Leukemia.
Sopper S, Mustjoki S, White D, Hughes T, Valent P, Burchert A, Gjertsen BT, Gastl G, Baldauf M, Trajanoski Z, Giles F, Hochhaus A, Ernst T, Schenk T, Janssen JJ, Ossenkoppele GJ, Porkka K, Wolf D. Sopper S, et al. J Clin Oncol. 2017 Jan 10;35(2):175-184. doi: 10.1200/JCO.2016.67.0893. Epub 2016 Nov 7. J Clin Oncol. 2017. PMID: 28056193
Safety and efficacy of switching to nilotinib 400 mg twice daily for patients with chronic myeloid leukemia in chronic phase with suboptimal response or failure on front-line imatinib or nilotinib 300 mg twice daily.
Hughes TP, Hochhaus A, Kantarjian HM, Cervantes F, Guilhot F, Niederwieser D, le Coutre PD, Rosti G, Ossenkoppele G, Lobo C, Shibayama H, Fan X, Menssen HD, Kemp C, Larson RA, Saglio G. Hughes TP, et al. Haematologica. 2014 Jul;99(7):1204-11. doi: 10.3324/haematol.2013.091272. Epub 2014 Feb 14. Haematologica. 2014. PMID: 24532039 Free PMC article. Clinical Trial.
20 results